MOH vs. CNC, HUM, ALGN, GMAB, WAT, COO, ALNY, ARGX, TEVA, and BNTX
Should you be buying Molina Healthcare stock or one of its competitors? The main competitors of Molina Healthcare include Centene (CNC), Humana (HUM), Align Technology (ALGN), Genmab A/S (GMAB), Waters (WAT), Cooper Companies (COO), Alnylam Pharmaceuticals (ALNY), argenx (ARGX), Teva Pharmaceutical Industries (TEVA), and BioNTech (BNTX). These companies are all part of the "medical" sector.
Centene (NYSE:CNC) and Molina Healthcare (NYSE:MOH) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, community ranking, analyst recommendations, valuation, risk, dividends, media sentiment and institutional ownership.
Centene received 486 more outperform votes than Molina Healthcare when rated by MarketBeat users. Likewise, 73.25% of users gave Centene an outperform vote while only 56.91% of users gave Molina Healthcare an outperform vote.
Centene has a beta of 0.41, meaning that its stock price is 59% less volatile than the S&P 500. Comparatively, Molina Healthcare has a beta of 0.54, meaning that its stock price is 46% less volatile than the S&P 500.
Centene currently has a consensus target price of $85.23, indicating a potential upside of 17.20%. Molina Healthcare has a consensus target price of $404.90, indicating a potential upside of 24.93%. Given Centene's higher probable upside, analysts plainly believe Molina Healthcare is more favorable than Centene.
Molina Healthcare has a net margin of 2.99% compared to Molina Healthcare's net margin of 1.76%. Centene's return on equity of 29.86% beat Molina Healthcare's return on equity.
93.6% of Centene shares are held by institutional investors. Comparatively, 98.5% of Molina Healthcare shares are held by institutional investors. 0.3% of Centene shares are held by insiders. Comparatively, 1.1% of Molina Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Centene has higher revenue and earnings than Molina Healthcare. Centene is trading at a lower price-to-earnings ratio than Molina Healthcare, indicating that it is currently the more affordable of the two stocks.
In the previous week, Centene had 7 more articles in the media than Molina Healthcare. MarketBeat recorded 21 mentions for Centene and 14 mentions for Molina Healthcare. Centene's average media sentiment score of 0.57 beat Molina Healthcare's score of 0.56 indicating that Molina Healthcare is being referred to more favorably in the news media.
Summary
Molina Healthcare beats Centene on 11 of the 18 factors compared between the two stocks.
Get Molina Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for MOH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MOH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Molina Healthcare Competitors List
Related Companies and Tools
